 Robert Dietz
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothermia, Induced | 6 | 2023 | 76 | 3.600 |
Why?
| | Hypoxia-Ischemia, Brain | 4 | 2023 | 34 | 2.750 |
Why?
| | Brain Ischemia | 10 | 2025 | 321 | 2.700 |
Why?
| | Hippocampus | 12 | 2025 | 874 | 1.530 |
Why?
| | TRPM Cation Channels | 3 | 2021 | 77 | 1.430 |
Why?
| | Heart Arrest | 6 | 2025 | 321 | 1.280 |
Why?
| | Recovery of Function | 4 | 2025 | 642 | 1.280 |
Why?
| | Asphyxia Neonatorum | 2 | 2018 | 18 | 1.090 |
Why?
| | Cerebral Palsy | 2 | 2018 | 96 | 1.000 |
Why?
| | Neurons | 8 | 2019 | 1511 | 0.890 |
Why?
| | Ischemia | 3 | 2023 | 406 | 0.830 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 110 | 0.780 |
Why?
| | Dexmedetomidine | 1 | 2022 | 43 | 0.760 |
Why?
| | Magnesium Sulfate | 2 | 2018 | 18 | 0.730 |
Why?
| | Cortical Spreading Depression | 3 | 2010 | 9 | 0.710 |
Why?
| | Long-Term Potentiation | 6 | 2025 | 197 | 0.710 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2020 | 226 | 0.680 |
Why?
| | Intensive Care, Neonatal | 1 | 2020 | 40 | 0.670 |
Why?
| | Infant, Newborn | 10 | 2023 | 5762 | 0.650 |
Why?
| | Hypothermia | 1 | 2018 | 34 | 0.600 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 161 | 0.590 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2019 | 114 | 0.590 |
Why?
| | Cognitive Dysfunction | 2 | 2019 | 346 | 0.560 |
Why?
| | Peptide Fragments | 1 | 2021 | 692 | 0.560 |
Why?
| | Zinc | 3 | 2010 | 294 | 0.560 |
Why?
| | Membrane Glycoproteins | 1 | 2018 | 474 | 0.490 |
Why?
| | Tinea | 1 | 2014 | 2 | 0.460 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 432 | 0.460 |
Why?
| | Calcium | 4 | 2017 | 1213 | 0.440 |
Why?
| | Premature Birth | 1 | 2017 | 314 | 0.440 |
Why?
| | Exanthema | 1 | 2014 | 74 | 0.430 |
Why?
| | Resuscitation | 1 | 2016 | 237 | 0.420 |
Why?
| | Animals | 24 | 2025 | 35361 | 0.390 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1501 | 0.390 |
Why?
| | Immunity, Innate | 1 | 2017 | 804 | 0.370 |
Why?
| | Oxidative Stress | 1 | 2017 | 1269 | 0.360 |
Why?
| | Gonadal Steroid Hormones | 2 | 2025 | 131 | 0.350 |
Why?
| | Hospitalization | 1 | 2020 | 2070 | 0.350 |
Why?
| | Cardiopulmonary Resuscitation | 3 | 2025 | 232 | 0.340 |
Why?
| | Neuronal Plasticity | 4 | 2023 | 280 | 0.330 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5440 | 0.330 |
Why?
| | Mice | 16 | 2025 | 16937 | 0.310 |
Why?
| | Infant, Premature | 3 | 2018 | 541 | 0.300 |
Why?
| | CA1 Region, Hippocampal | 2 | 2019 | 52 | 0.290 |
Why?
| | Sodium-Calcium Exchanger | 1 | 2007 | 16 | 0.270 |
Why?
| | Stroke | 3 | 2022 | 1071 | 0.270 |
Why?
| | Cognition | 3 | 2019 | 1123 | 0.260 |
Why?
| | Dendrites | 1 | 2007 | 100 | 0.250 |
Why?
| | Humans | 17 | 2023 | 129650 | 0.220 |
Why?
| | Infant | 4 | 2019 | 9024 | 0.210 |
Why?
| | Multiple Organ Failure | 1 | 2023 | 122 | 0.210 |
Why?
| | Male | 16 | 2025 | 63681 | 0.200 |
Why?
| | Cerebral Infarction | 1 | 2022 | 42 | 0.200 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 23 | 0.190 |
Why?
| | Female | 12 | 2025 | 68776 | 0.190 |
Why?
| | Organ Culture Techniques | 1 | 2021 | 154 | 0.180 |
Why?
| | Morphine | 1 | 2022 | 137 | 0.180 |
Why?
| | Blood-Brain Barrier | 1 | 2022 | 132 | 0.180 |
Why?
| | Memory Disorders | 2 | 2019 | 168 | 0.180 |
Why?
| | Brain | 2 | 2023 | 2679 | 0.180 |
Why?
| | Chelating Agents | 3 | 2010 | 68 | 0.170 |
Why?
| | Nogo Proteins | 1 | 2019 | 9 | 0.160 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2019 | 68 | 0.160 |
Why?
| | Heparitin Sulfate | 1 | 2019 | 43 | 0.160 |
Why?
| | Brain Injuries | 2 | 2017 | 468 | 0.160 |
Why?
| | Membrane Potentials | 3 | 2010 | 293 | 0.150 |
Why?
| | Calcineurin | 1 | 2019 | 98 | 0.150 |
Why?
| | Nerve Net | 1 | 2021 | 260 | 0.150 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2020 | 170 | 0.150 |
Why?
| | Standard of Care | 1 | 2018 | 72 | 0.150 |
Why?
| | Aging | 2 | 2019 | 1776 | 0.150 |
Why?
| | Ouabain | 2 | 2008 | 18 | 0.140 |
Why?
| | Lateral Ventricles | 1 | 2018 | 36 | 0.140 |
Why?
| | Myelin Proteolipid Protein | 1 | 2018 | 62 | 0.140 |
Why?
| | Magnesium | 1 | 2017 | 153 | 0.140 |
Why?
| | In Vitro Techniques | 3 | 2008 | 1085 | 0.140 |
Why?
| | Hyperoxia | 1 | 2017 | 90 | 0.130 |
Why?
| | Infant, Premature, Diseases | 1 | 2018 | 93 | 0.130 |
Why?
| | Neuroprotection | 1 | 2017 | 38 | 0.130 |
Why?
| | Calcium Channel Blockers | 2 | 2008 | 161 | 0.130 |
Why?
| | Mice, Knockout | 3 | 2019 | 2871 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2022 | 4063 | 0.130 |
Why?
| | Age Factors | 2 | 2021 | 3144 | 0.130 |
Why?
| | Axons | 1 | 2018 | 191 | 0.130 |
Why?
| | Myelin Sheath | 1 | 2018 | 160 | 0.130 |
Why?
| | Calcium Channels, T-Type | 1 | 2017 | 94 | 0.120 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2016 | 120 | 0.120 |
Why?
| | Macaca mulatta | 1 | 2016 | 149 | 0.120 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 122 | 0.120 |
Why?
| | Pregnancy | 2 | 2018 | 6402 | 0.120 |
Why?
| | Signal Transduction | 2 | 2019 | 4925 | 0.120 |
Why?
| | Lung Injury | 1 | 2017 | 210 | 0.120 |
Why?
| | History, 20th Century | 1 | 2016 | 291 | 0.110 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 185 | 0.110 |
Why?
| | Behavior, Animal | 1 | 2018 | 508 | 0.110 |
Why?
| | Enzyme Inhibitors | 2 | 2008 | 827 | 0.110 |
Why?
| | Intestinal Atresia | 1 | 2014 | 14 | 0.110 |
Why?
| | Action Potentials | 1 | 2017 | 486 | 0.110 |
Why?
| | Animals, Newborn | 1 | 2016 | 835 | 0.100 |
Why?
| | Brain Injuries, Traumatic | 1 | 2018 | 341 | 0.100 |
Why?
| | Sepsis | 1 | 2019 | 574 | 0.100 |
Why?
| | Intestine, Small | 1 | 2014 | 150 | 0.100 |
Why?
| | Mitochondria | 2 | 2009 | 877 | 0.100 |
Why?
| | Abnormalities, Multiple | 1 | 2014 | 178 | 0.100 |
Why?
| | Colon | 1 | 2014 | 254 | 0.090 |
Why?
| | Urinary Bladder | 1 | 2014 | 175 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 925 | 0.090 |
Why?
| | Colorado | 1 | 2020 | 4421 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 2012 | 0.080 |
Why?
| | Adenosine A1 Receptor Antagonists | 1 | 2008 | 2 | 0.080 |
Why?
| | Ethylenediamines | 1 | 2008 | 6 | 0.080 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 51 | 0.070 |
Why?
| | Electrophysiology | 1 | 2008 | 212 | 0.070 |
Why?
| | Potassium | 1 | 2008 | 143 | 0.070 |
Why?
| | Mice, Inbred Strains | 1 | 2008 | 406 | 0.070 |
Why?
| | Calcium Channels, L-Type | 1 | 2008 | 117 | 0.070 |
Why?
| | Nimodipine | 1 | 2007 | 8 | 0.070 |
Why?
| | N-Methylaspartate | 1 | 2007 | 39 | 0.070 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2007 | 40 | 0.070 |
Why?
| | Calcium Signaling | 1 | 2009 | 250 | 0.070 |
Why?
| | Glucose | 2 | 2010 | 1003 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2010 | 743 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2007 | 279 | 0.060 |
Why?
| | Sodium | 1 | 2007 | 206 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2020 | 10230 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2023 | 2406 | 0.060 |
Why?
| | Ovariectomy | 1 | 2025 | 137 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2010 | 1119 | 0.060 |
Why?
| | Endocarditis, Bacterial | 1 | 2004 | 42 | 0.050 |
Why?
| | Aged | 1 | 2022 | 22103 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2020 | 14518 | 0.050 |
Why?
| | Rats | 2 | 2023 | 5500 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 175 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1968 | 0.050 |
Why?
| | Hypoxia | 1 | 2008 | 1084 | 0.050 |
Why?
| | Blood Platelets | 1 | 2004 | 380 | 0.040 |
Why?
| | Cerebellum | 1 | 2022 | 219 | 0.040 |
Why?
| | Staphylococcal Infections | 1 | 2004 | 393 | 0.040 |
Why?
| | Thalamic Nuclei | 1 | 2018 | 10 | 0.040 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2018 | 21 | 0.040 |
Why?
| | Long-Term Synaptic Depression | 1 | 2018 | 56 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2018 | 141 | 0.030 |
Why?
| | Memory | 1 | 2019 | 255 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 127 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 169 | 0.030 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.030 |
Why?
| | Time Factors | 2 | 2017 | 6556 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2017 | 441 | 0.030 |
Why?
| | Microglia | 1 | 2018 | 235 | 0.030 |
Why?
| | Cell Death | 1 | 2017 | 354 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2018 | 437 | 0.030 |
Why?
| | Prune Belly Syndrome | 1 | 2014 | 7 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1717 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 911 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 697 | 0.030 |
Why?
| | Syndrome | 1 | 2014 | 341 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 1713 | 0.020 |
Why?
| | Radiography | 1 | 2014 | 798 | 0.020 |
Why?
| | Hypoxia, Brain | 1 | 2010 | 8 | 0.020 |
Why?
| | Edetic Acid | 1 | 2010 | 46 | 0.020 |
Why?
| | Polycyclic Compounds | 1 | 2010 | 14 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2010 | 40 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2010 | 109 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2391 | 0.020 |
Why?
| | Pyramidal Cells | 1 | 2010 | 73 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3408 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1434 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2010 | 149 | 0.020 |
Why?
| | Cation Transport Proteins | 1 | 2010 | 132 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 317 | 0.020 |
Why?
| | Nafcillin | 1 | 2004 | 3 | 0.010 |
Why?
| | Penicillins | 1 | 2004 | 57 | 0.010 |
Why?
| | Staphylococcus | 1 | 2004 | 74 | 0.010 |
Why?
| | Vancomycin | 1 | 2004 | 78 | 0.010 |
Why?
| | Microbial Sensitivity Tests | 1 | 2004 | 352 | 0.010 |
Why?
| | Rabbits | 1 | 2004 | 778 | 0.010 |
Why?
| | Heart | 1 | 2004 | 637 | 0.010 |
Why?
| | Child | 1 | 2019 | 20883 | 0.010 |
Why?
|
|
Dietz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|